We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$395B
AUM Growth
+$8.56B
Cap. Flow
+$9.34B
Cap. Flow %
2.36%
Top 10 Hldgs %
27.43%
Holding
14,748
New
1,670
Increased
4,598
Reduced
5,766
Closed
2,485

Sector Composition

Rank Sector Weight
1 Technology 2.06%
2 Consumer Discretionary 1.55%
3 Financials 1.15%
4 Healthcare 0.97%
5 Communication Services 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUCK
13826
CALL
Lucky Strike Entertainment
LUCK
$915M
-13,700
Closed -$169K
PVLA
13827
CALL
Palvella Therapeutics
PVLA
$2.1B
-296
Closed -$27K
PHLT
13828
PUT
DELISTED
Performant Healthcare Inc
PHLT
-39,900
Closed -$74K
NPKI
13829
CALL
NPK International
NPKI
$1.12B
-23,000
Closed -$58K
NPKI
13830
PUT
NPK International
NPKI
$1.12B
-10,000
Closed -$25K
JXG
13831
JX Luxventure
JXG
$91.5M
-59
Closed -$31K
OUSTZ
13832
DELISTED
Ouster Inc Warrants
OUSTZ
-23,246
Closed -$4K
AAMI
13833
Acadian Asset Management
AAMI
$3.26B
-14,416
Closed -$272K
PRSU
13834
CALL
Pursuit Attractions and Hospitality Inc
PRSU
$1.33B
-7,100
Closed -$224K
PRSU
13835
Pursuit Attractions and Hospitality Inc
PRSU
$1.33B
-7,409
Closed -$234K
JBTM
13836
JBT Marel
JBTM
$5.97B
-16,446
Closed -$1.41M
JBTM
13837
PUT
JBT Marel
JBTM
$5.97B
-2,500
Closed -$215K
RNTX
13838
Rein Therapeutics
RNTX
$69M
-2,521
Closed -$10K
DVLT
13839
Datavault AI
DVLT
$267M
-2
Closed -$17K
CTEV
13840
PUT
Claritev Corp
CTEV
$620M
-1,298
Closed -$148K
FFAIW
13841
DELISTED
Faraday Future Intelligent Electric Warrant
FFAIW
-49,167
Closed -$7K
KLRS
13842
Kalaris Therapeutics
KLRS
$97.6M
-1,449
Closed -$263K
NAGE
13843
Niagen Bioscience
NAGE
$254M
-95,620
Closed -$118K
TVRD
13844
Tvardi Therapeutics
TVRD
$23.7M
-1,870
Closed -$710K
TPC
13845
CALL
Tutor Perini Cor
TPC
$4.64B
-24,500
Closed -$135K
BCPC
13846
CALL
Balchem Corp
BCPC
$5.66B
-2,800
Closed -$340K
LGF.A
13847
PUT
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-41,700
Closed -$310K
CRUZ
13848
DELISTED
Defiance Hotel, Airline, and Cruise ETF
CRUZ
-11,652
Closed -$164K
MKFG
13849
PUT
DELISTED
Markforged Holding Corporation
MKFG
-2,190
Closed -$43K
CSA
13850
DELISTED
VictoryShares US Small Cap Volatility Wtd ETF
CSA
-6,722
Closed -$358K

Similar funds

Jeff Yass's Q4 2022 Portfolio in Review

As of Q4 2022, Jeff Yass held 14,748 positions worth $395B, up 2.2% from $387B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass's Q4 2022 filing shows 1,670 new, 4,598 increased, 5,766 reduced and 2,485 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M. The largest sale was Amazon, an estimated $1.48B.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.9% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jeff Yass's largest Q4 2022 buy was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M.
  • Jeff Yass added most to Tesla in Q4 2022, an estimated $2.17B increase.
  • Jeff Yass's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.48B.
  • Jeff Yass fully exited Twitter, Inc. in Q4 2022, selling an estimated $76M.
  • Jeff Yass's ten largest holdings make up 27% of its $395B portfolio in Q4 2022.
  • Jeff Yass opened 1,670 new positions and closed 2,485 in Q4 2022.
  • Jeff Yass's portfolio value rose 2.2% quarter-over-quarter to $395B.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.